Senate committee sets key vote for Trump FDA nominee
Summary
The Senate health committee scheduled a vote on Nov. 18 on Dr. Heidi Overton’s nomination to lead the Food and Drug Administration. Her nomination’s path forward remains uncertain, according to the article.Key Facts
- The Senate health committee announced the vote in a press release.
- The committee scheduled the vote for Nov. 18.
- The vote concerns Dr. Heidi Overton’s nomination.
- Overton is nominated to serve as FDA commissioner.
- The article says her path forward is not assured.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
